Correlation Between Apellis Pharmaceuticals and Immunic
Can any of the company-specific risk be diversified away by investing in both Apellis Pharmaceuticals and Immunic at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apellis Pharmaceuticals and Immunic into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Apellis Pharmaceuticals and Immunic, you can compare the effects of market volatilities on Apellis Pharmaceuticals and Immunic and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apellis Pharmaceuticals with a short position of Immunic. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apellis Pharmaceuticals and Immunic.
Diversification Opportunities for Apellis Pharmaceuticals and Immunic
0.3 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Apellis and Immunic is 0.3. Overlapping area represents the amount of risk that can be diversified away by holding Apellis Pharmaceuticals and Immunic in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immunic and Apellis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apellis Pharmaceuticals are associated (or correlated) with Immunic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immunic has no effect on the direction of Apellis Pharmaceuticals i.e., Apellis Pharmaceuticals and Immunic go up and down completely randomly.
Pair Corralation between Apellis Pharmaceuticals and Immunic
Given the investment horizon of 90 days Apellis Pharmaceuticals is expected to under-perform the Immunic. But the stock apears to be less risky and, when comparing its historical volatility, Apellis Pharmaceuticals is 1.18 times less risky than Immunic. The stock trades about -0.03 of its potential returns per unit of risk. The Immunic is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 106.00 in Immunic on August 26, 2024 and sell it today you would earn a total of 4.00 from holding Immunic or generate 3.77% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Apellis Pharmaceuticals vs. Immunic
Performance |
| Timeline |
| Apellis Pharmaceuticals |
| Immunic |
Apellis Pharmaceuticals and Immunic Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Apellis Pharmaceuticals and Immunic
The main advantage of trading using opposite Apellis Pharmaceuticals and Immunic positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apellis Pharmaceuticals position performs unexpectedly, Immunic can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immunic will offset losses from the drop in Immunic's long position.| Apellis Pharmaceuticals vs. Eliem Therapeutics | Apellis Pharmaceuticals vs. HCW Biologics | Apellis Pharmaceuticals vs. Scpharmaceuticals | Apellis Pharmaceuticals vs. Milestone Pharmaceuticals |
| Immunic vs. Generation Bio Co | Immunic vs. Kronos Bio | Immunic vs. Erasca Inc | Immunic vs. C4 Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Complementary Tools
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |